Manzanita Pharmaceuticals is a biopharma company developing non-opiate, pen-injectable product (glucocorticoids) for the treatment of chronic pain. The company was founded in May 2007 with the acquisition of intellectual property assets of Asilomar Pharmaceuticals (Asilomar filed for bankruptcy in June 2006). The company developing a protein-drug conjugate which is a combination of glucocorticoid with recombinant human nerve growth factor protein for the treatment of chronic pain (Phase 2a).
View Top Employees from MANZANITA PHARMACEUTICALS INCWebsite | https://www.manzanitapharma.com |
Revenue | $4 million |
Employees | 5 (1 on RocketReach) |
Founded | 2007 |
Address | 2995 WOODSIDE ROAD SUITE 400, Woodside, California 94062, US |
Phone | (408) 348-3191 |
Technologies | |
Industry | Pharmaceutical Manufacturing, Business Services General, Business Services |
SIC | SIC Code 87 Companies, SIC Code 873 Companies |
NAICS | NAICS Code 54171 Companies, NAICS Code 54 Companies, NAICS Code 541714 Companies, NAICS Code 541 Companies, NAICS Code 5417 Companies |
Looking for a particular MANZANITA PHARMACEUTICALS INC employee's phone or email?
The MANZANITA PHARMACEUTICALS INC annual revenue was $4 million in 2024.
1 people are employed at MANZANITA PHARMACEUTICALS INC.
MANZANITA PHARMACEUTICALS INC is based in Woodside, California.
The NAICS codes for MANZANITA PHARMACEUTICALS INC are [54171, 54, 541714, 541, 5417].
The SIC codes for MANZANITA PHARMACEUTICALS INC are [87, 873].